Host genes important to HIV replication and evolution

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 4, 2012, Pages

  Telenti, Amalio ^a   Johnson, Welkin E ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE CCL3L1; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR6; HLA B ANTIGEN; HLA C ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE COURSE; ENDOGENOUS RETROVIRUS; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOMICS; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR EVOLUTION; NONHUMAN; PALEOVIROLOGY; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; SYNECOLOGY; SYSTEMS BIOLOGY; VIRUS REPLICATION; ANIMAL; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRUS INFECTION; PHYSIOLOGY; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES;

ANIMALS; CHEMOKINES; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HIV INFECTIONS; HIV-1; HUMANS; LENTIVIRUS INFECTIONS; RECEPTORS, CHEMOKINE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 84864421608     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007203     Document Type: Article

References (138)

1. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothe BR, Vogel TU, Dunphy E, LieblME, Emerson C, Wilson N, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.
2. Ambrose Z, KewalRamani VN, Bieniasz PD, Hatziioannou T. 2007. HIV/AIDS: In search of an animal model. Trends Biotechnol 25: 333-337.
3. Amit I, Garber M, Chevrier N, Leite AP, Donner Y, Eisenhaure T, Guttman M, Grenier JK, Li W, Zuk O, et al. 2009. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326: 257-263.
4. Apetrei C, Robertson DL, Marx PA. 2004. The history of SIVS and AIDS: Epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front Biosci 9: 225-254.
5. Ballana E, Senserrich J, Pauls E, Faner R, Mercader JM, Uyttebroeck F, Palou E, Mena MP, Grau E, Clotet B, et al. 2010. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 50: 1022-1032.
6. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, Carlson J, Yusim K, McMahon B, Gaschen B, et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315: 1583-1586.
7. Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM. 2009. CCL3L1 and HIV/AIDS susceptibility. Nat Med 15: 1112-1115.
8. Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, Francella N, Sidahmed A, Smith AJ, Cramer EM, et al. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119: 3556-3572.
9. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
10. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
11. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, Konig R, et al. 2009. Host cell factors in HIV replication: Meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437. doi: 10. 1371/journal. ppat. 1000437.
12. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, KaslowR, Buchbinder S, Hoots K, O'Brien SJ. 1999. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
13. + cell proteome: Dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol 81: 7571-7583.
14. Chen Z, Kwon D, Jin Z, Monard S, Telfer P, Jones MS, Lu CY, Aguilar RF, Ho DD, Marx PA. 1998. Natural infection of a homozygous Δ24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 188: 2057-2065.
15. + T cells. Science 270: 1811-1815.
16. Colantonio AD, Bimber BN, Neidermyer WJ, Reeves RK, Alter G, Altfeld M, Johnson RP, Carrington M, O'Connor DH, Evans DT. 2011. KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. PLoS Pathog 7: e1001316. doi: 10. 1371/journal. ppat. 1001316.
17. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, LambotteO, Avettand-Fenoel V, Le CS, de Senneville LD, et al. 2008. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: The ANRS genome wide association 01 study. PLoS One 3: e3907. doi: 10. 1371/journal. pone. 0003907.
18. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. 1985. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228: 1201-1204.
19. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, GoedertJJ, Buchbinder SP, Vittinghoff E, Gomperts E, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco City cohort, ALIVE study. Science 273: 1856-1862.
20. Degenhardt JD, de Candia P, Chabot A, Schwartz S, Henderson L, Ling B, Hunter M, Jiang Z, Palermo RE, Katze M, et al. 2009. Copy number variation ofCCL3-like genes affects rate of progression to simian-AIDS in Rhesus Macaques (Macaca mulatta). PLoS Genet 5: e1000346. doi: 10. 1371/journal. pgen. 1000346.
21. de Groot NG, Heijmans CM, Zoet YM, de Ru AH, Verreck FA, van Veelen PA, Drijfhout JW, Doxiadis GG, Remarque EJ, Doxiadis II, et al. 2010. AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc Natl Acad Sci 107: 15175-15180.
22. Draenert R, Allen TM, Liu Y, Wrin T, Chappey C, Verrill CL, Sirera G, EldridgeRL, Lahaie MP, Ruiz L, et al. 2006. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J Exp Med 203: 529-539.
23. Emerman M, Malik HS. 2010. Paleovirology-Modern consequences of ancient viruses. PLoS Biol 8: e1000301. doi: 10. 1371/journal. pbio. 1000301.
24. Evangelou E, Fellay J, Colombo S, Martinez-Picado J, Obel N, Goldstein DB, Telenti A, Ioannidis JP. 2011. Impact of phenotype definition on genome-wide association signals: Empirical evaluation in HIV-1 infection. Am J Epidemiol 173: 1336-1342.
25. Evans DT, O'Connor DH, Jing P, Dzuris JL, Sidney J, da Silva J, Allen TM, HortonH, Venham JE, Rudersdorf RA, et al. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 5: 1270-1276.
26. Fan QR, Long EO, Wiley DC. 2001. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2: 452-460.
27. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
28. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, et al. 2009. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791. doi: 10. 1371/journal. pgen. 1000791.
29. Fellay J, Shianna KV, Telenti A, Goldstein DB. 2010. Host genetics and HIV-1: The final phase? PLoS Pathog 6: e1001033. doi: 10. 1371/journal. ppat. 1001033.
30. Fellay J, Frahm N, Shianna KV, Cirulli ET, Casimiro DR, Robertson MN, HaynesBF, Geraghty DE, McElrath MJ, Goldstein DB. 2011. Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial. J Infect Dis 203: 773-779.
31. Fu W, Sanders-Beer BE, Katz KS, Maglott DR, Pruitt KD, Ptak RG. 2009. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 37: D417-D422.
32. Gardner MB. 2003. Simian AIDS: An historical perspective. J Med Primatol 32: 180-186.
33. Gilbert C, Maxfield DG, Goodman SM, Feschotte C. 2009. Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet 5: e1000425. doi: 10. 1371/journal. pgen. 1000425.
34. Giri MS, Nebozhyn M, Showe L, Montaner LJ. 2006. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J Leukoc Biol 80: 1031-1043.
35. Goldschmidt V, Bleiber G, May M, Martinez R, Ortiz M, Telenti A. 2006. Role of common human TRIM5α variants in HIV-1 disease progression. Retrovirology 3: 54.
36. Goldschmidt V, Ciuffi A, Ortiz M, Brawand D, Munoz M, Kaessmann H, TelentiA. 2008. Antiretroviral activity of ancestral TRIM5α. J Virol 82: 2089-2096.
37. + T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication. J Virol 74: 9388-9395.
38. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, et al. 2005. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
39. Grossman SR, Shylakhter I, Karlsson EK, Byrne EH, Morales S, Frieden G, Hostetter E, Angelino E, Garber M, Zuk O, et al. 2010. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327: 883-886.
40. Hahn BH, Shaw GM, De Cock KM, Sharp PM. 2000. AIDS as a zoonosis: Scientific and public health implications. Science 287: 607-614.
41. Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34: 1673-1679.
42. Hatziioannou T, Princiotta M, Piatak M Jr., Yuan F, Zhang F, Lifson JD, BieniaszPD. 2006. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314: 95.
43. Hatziioannou T, Ambrose Z, Chung NP, Piatak M Jr., Yuan F, Trubey CM, Coalter V, Kiser R, Schneider D, Smedley J, et al. 2009. A macaque model of HIV-1 infection. Proc Natl Acad Sci 106: 4425-4429.
44. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, TroyerJL, Goedert JJ, Kessing BD, et al. 2010. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201: 618-626.
45. Hirsch V, Adger-Johnson D, Campbell B, Goldstein S, Brown C, Elkins WR, Montefiori DC. 1997. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 71: 1608-1620.
46. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2: 1240-1243.
47. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, LeeC. 2004. Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
48. Igarashi T, Iyengar R, Byrum RA, Buckler-White A, Dewar RL, Buckler CE, LaneHC, Kamada K, Adachi A, Martin MA. 2007. Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J Virol 81: 11549-11552.
49. International HIV Controllers Study. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
50. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, Dillies MA, Roques P, Butor C, Silvestri G, et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119: 3544-3555.
51. Javanbakht H, An P, Gold B, Petersen DC, O'Huigin C, Nelson GW, O'Brien SJ, Kirk GD, Detels R, Buchbinder S, et al. 2006. Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354: 15-27.
52. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5: e1000429. doi: 10. 1371/journal. ppat. 1000429.
53. Johnson WE. 2010. Endless forms most viral. PLoS Genet 6: e1001210. doi: 10. 1371/journal. pgen. 1001210.
54. Kaiser SM, Malik H, Emerman M. 2007. Restriction of an extinct retrovirus by the human TRIM5 α antiviral protein. Science 316: 1756-1758.
55. Kamada K, Igarashi T, Martin MA, Khamsri B, Hatcho K, Yamashita T, Fujita M, Uchiyama T, Adachi A. 2006. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc Natl Acad Sci 103: 16959-16964.
56. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. NatMed 2: 405-411.
57. Katzourakis A, Gifford RJ. 2010. Endogenous viral elements in animal genomes. PLoS Genet 6: e1001191. doi: 10. 1371/journal. pgen. 1001191.
58. Katzourakis A, Tristem M, Pybus OG, Gifford RJ. 2007. Discovery and analysis of the first endogenous lentivirus. Proc Natl Acad Sci 104: 6261-6265.
59. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
60. Keckesova Z, Ylinen LM, Towers GJ, Gifford RJ, Katzourakis A. 2009. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 384: 7-11.
61. King CR, Rathouz PJ, Nicolae DL. 2010. An evolutionary framework for association testing in resequencing studies. PLoS Genet 6: e1001202. doi: 10. 1371/journal. pgen. 1001202.
62. Kirmaier A, Wu F, Newman RM, Hall LR, Morgan JS, O'Connor S, Marx PA, Meythaler M, Goldstein S, Buckler-White A, et al. 2010. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 8: e1000462. doi: 10. 1371/journal. pbio. 1000462.
63. Klatt NR, Silvestri G, Hirsch V. 2011. Nonpathogenic simian immunodeficiency virus infections. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a007153.
64. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, TuBP, De Jesus PD, Lilley CE, et al. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
65. Kulkarni SS, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks S, Telenti A, et al. 2011. Differential microRNA regulation of HLA-C expression and it association with HIV control. Nature 472: 495-498.
66. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R, Deveau C, et al. 2009. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 200: 1194-1201.
67. Lederer S, Favre D, Walters KA, Proll S, Kanwar B, Kasakow Z, Baskin CR, Palermo R, McCune JM, Katze MG. 2009. Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 5: e1000296. doi: 10. 1371/journal. ppat. 1000296.
68. Lee AS, Gutierrez-Arcelus M, Perry GH, Vallender EJ, Johnson WE, Miller GM, Korbel JO, Lee C. 2008. Analysis of copy number variation in the rhesus macaque genome identifies candidate loci for evolutionary and human disease studies. Hum Mol Genet 17: 1127-1136.
69. Lefebvre G, Desfarges S, Uyttebroeck F, Muñoz M, Beerenwinkel N, RougemontJ, Telenti A, Ciuffi A. 2011. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol 85: 6205-6211.
70. Liao CH, Kuang YQ, Liu HL, Zheng YT, Su B. 2007. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 21 (Suppl 8): S19-S26.
71. Lifson JD, Haigwood NL. 2011. Lessons in nonhuman primate models for AIDS vaccine research: From minefields to milestones. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a007310.
72. Lim SY, Rogers T, Chan T, Whitney JB, Kim J, Sodroski J, Letvin NL. 2010a. TRIM5α modulates v control in Rhesus Monkeys. PLoS Pathog 6: e1000738. doi: 10. 1371/journal. ppat. 1000738.
73. Lim SY, Chan T, Gelman RS, Whitney JB, O'Brien KL, Barouch DH, Goldstein DB, Haynes BF, Letvin NL. 2010b. Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeys. PLoS Genet 6: e1000997. doi: 10. 1371/journal. pgen. 1000997.
74. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, et al. 2009. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199: 419-426.
75. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, et al. 2010. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis 202: 908-915.
76. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
77. Loeuillet C, Deutsch S, Ciuffi A, Robyr D, Taffe P, Munoz M, Beckmann JS, Antonarakis SE, Telenti A. 2008. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol 6: e32. doi: 10. 1371/journal. pbio. 0060032.
78. + T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. PLoS One 2: e1152. doi: 10. 1371/journal. pone. 0001152.
79. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, BealDR, Wilson NA, Rehrauer WM, et al. 2007b. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 81: 8827-8832.
80. Malhi RS, Sickler B, Lin D, Satkoski J, Tito RY, George D, Kanthaswamy S, SmithDG. 2007. MamuSNP: A resource for Rhesus Macaque (Macaca mulatta) genomics. PLoS ONE 2: e438. doi: 10. 1371/journal. pone. 0000438.
81. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016-1018.
82. Mandelboim O, Wilson SB, Vales-Gomez M, Reyburn HT, Strominger JL. 1997. Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci 94: 4604-4609.
83. Mansfield KG, Lerch NW, Gardner MB, Lackner AA. 1995. Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J Med Primatol 24: 116-122.
84. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, HootsK, Vlahov D, Trowsdale J, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434.
85. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740.
86. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD. 2009. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5: e1000300. doi: 10. 1371/journal. ppat. 1000300.
87. Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D, Proost P, Van Damme J. 1999. The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J Clin Invest 104: R1-R5.
88. Menten P, Wuyts A, Van Damme J. 2002. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13: 455-481.
89. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
90. Newman RM, Hall L, Connole M, Chen GL, Sato S, Yuste E, Diehl W, Hunter E, Kaur A, Miller GM, et al. 2006. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc Natl Acad Sci 103: 19134-19139.
91. Nguyen DG, Yin H, Zhou Y, Wolff KC, Kuhen KL, Caldwell JS. 2007. Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening. Virology 362: 16-25.
92. Nibbs RJ, Yang J, Landau NR, Mao JH, Graham GJ. 1999. LD78β, a non-allelic variant of human MIP-1α (LD78α), has enhanced receptor interactions and potent HIV suppressive activity. J Biol Chem 274: 17478-17483.
93. Nisole S, Lynch C, Stoye JP, Yap MW. 2004. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci 101: 13324-13328.
94. O'Connor SL, Lhost JJ, Becker EA, Detmer AM, Johnson RC, Macnair CE, Wiseman RW, Karl JA, Greene JM, Burwitz BJ, et al. 2010. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci Trans Med 2: 22ra18.
95. Palacios E, Digilio L, McClure HM, Chen Z, Marx PA, Goldsmith MA, Grant RM. 1998. Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol 8: 943-946.
96. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, et al. 2010. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11: 1127-1135.
97. Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, Shianna KV, Gumbs C, Gao X, Maia JM, Cronin KD, et al. 2010. Host determinants of HIV-1 control in African Americans. J Infect Dis 201: 1141-1149.
98. Perry GH, Tchinda J, McGrath SD, Zhang J, Picker SR, Caceres AM, Iafrate AJ, Tyler-Smith C, Scherer SW, Eichler EE, et al. 2006. Hotspots for copy number variation in chimpanzees and humans. Proc Natl Acad Sci 103: 8006-8011.
99. Peruzzi M, Parker KC, Long EO, Malnati MS. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157: 3350-3356.
100. + T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 16: 1147-1151.
101. Rahm N, Yap M, Snoeck J, Zoete V, Munoz M, Radespiel U, Zimmermann E, Michielin O, Stoye JP, Ciuffi A, et al. 2011. Unique spectrum of activity of prosimian TRIM5α against exogenous and endogenous retroviruses. J Virol 85: 4173-4183.
102. Rajagopalan S, Long EO. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185: 1523-1528.
103. Riddick NE, Hermann EA, Loftin LM, Elliott ST, Wey WC, Cervasi B, Taaffe J, Engram JC, Li B, Else JG, et al. 2010. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 6: e1001064. doi: 10. 1371/journal. ppat. 1001064.
104. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D. 2008. Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 82: 4320-4330.
105. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, et al. 2011. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 17: 366-371.
106. Rosner C, Kruse PH, Hermes M, Otto N, Walter L. 2011. Rhesus macaque inhibitory and activating KIR3D interact with Mamu-A-encoded ligands. J Immunol 186: 2156-2163.
107. + T-cells from HIV-1-infected individuals. PLoS Pathog 6: e1000781. doi: 10. 1371/journal. ppat. 1000781.
108. Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Marttinez R, Sandler NG, Roque A, Liebner J, Battegay M, et al. 2011. Comparative transcriptome analysis of extreme phenotypes of human HIV-1 infection and sooty mangabey and rhesus macaque models of SIV infection. J Clin Invest 121: 2391-2400.
109. Sayah DM, Luban J. 2004. Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection. J Virol 78: 12066-12070.
110. + lymphocytes. Science 283: 857-860.
111. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
112. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
113. Serra-Moreno R, Jia B, Breed M, Alvarez X, Evans DT. 2011. Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 9: 46-57.
114. Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, Yawata M, Pando M, Thananchai H, Dong T, Rowland-Jones S, et al. 2009. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 183: 4569-4582.
115. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDs pandemic. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006841.
116. Silvestri G. 2010. Pathogenic vs. nonpathogenic retrovirus infections. Presented at the Conference on Retroviruses and Opportunistic Infections. San Francisco, February 16-19, 2010.
117. Snijder B, Sacher R, Ramo P, Damm EM, Liberali P, Pelkmans L. 2009. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 461: 520-523.
118. Soll SJ, Neil SJ, Bieniasz PD. 2010. Identification of a receptor for an extinct virus. Proc Natl Acad Sci 107: 19496-19501.
119. Speelmon EC, Livingston-Rosanoff D, Li SS, Vu Q, Bui J, Geraghty DE, Zhao LP, McElrath MJ. 2006. Genetic association of the antiviral restriction factor TRIM5α with human immunodeficiency virus type 1 infection. J Virol 80: 2463-2471.
120. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
121. Tang J, Costello C, Keet IP, Rivers C, Leblanc S, Karita E, Allen S, Kaslow RA. 1999. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 15: 317-324.
122. Telenti A. 2009. HIV-1 host interactions-Integration of large scale datasets. F1000 Biol Rep 1: 71.
123. Telenti A, Goldstein DB. 2006. Genomics meets HIV. Nat Rev Microbiol 4: 9-18.
124. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, Easterbrook P, McVicar DW, Maenaka K, Parham P, et al. 2007. Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178: 33-37.
125. Thomas R, Apps R, Qi Y, Gao X, Male V, O'HUigin C, O'Connor G, Ge D, Fellay J, Martin JN, et al. 2009. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41: 1290-1294.
126. Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, et al. 2009. CCL3L1 and HIV/AIDS susceptibility. Nat Med 15: 1110-1112.
127. Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, ChurchG, Martinez-Picado J, Rosenberg ES, et al. 2011. Transcriptional profiling of CD4 T cells identifiesd subgroups of HIV-1 elite controllers. J Virol 85: 3015-3019.
128. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr., Swanstrom R, BurchCL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460: 711-716.
129. Weiler A, May GE, Qi Y, Wilson N, Watkins DI. 2006. Polymorphisms in eight host genes associated with control of HIV replication do not mediate elite control of viral replication in SIV-infected Indian rhesus macaques. Immunogenetics 58: 1003-1009.
130. Wilson SJ, Webb BL, Maplanka C, Newman RM, Verschoor EJ, Heeney JL, TowersGJ. 2008. Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J Virol 82: 7243-7247.
131. Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, ProsserAT, Torimiro JN, Wright A, Mpoudi-Ngole E, et al. 2004. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363: 932-937.
132. Xin X, Shioda T, Kato A, Liu H, Sakai Y, Nagai Y. 1999. Enhanced anti-HIV-1 activity of CC-chemokine LD78β, a non-allelic variant of MIP-1α/LD78α. FEBS Lett 457: 219-222.
133. Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI. 2006. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 80: 5074-5077.
134. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. 2009. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 284: 19463-19473.
135. Yoon W, Ma BJ, Fellay J, Huang W, Xia SM, Zhang R, Shianna KV, Liao HX, Haynes BF, Goldstein DB. 2010. A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro. AIDS 24: 155-157.
136. Zappacosta F, Borrego F, Brooks AG, Parker KC, Coligan JE. 1997. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci 94: 6313-6318.
137. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6: 54-67.
138. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, et al. 2008. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4: 495-504.